A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells
Xiuli Wang(City of Hope), Michael C. Jensen(Seattle Children's Hospital), David Colcher(City Of Hope National Medical Center), Stanley R. Riddell(Fred Hutch Cancer Center), Wen-Chung Chang(City Of Hope National Medical Center), Mark A. Sherman(Prudential Financial (United States)), Julie R. Ostberg(CTI BioPharma (United Kingdom)), ChingLam W. Wong(City Of Hope National Medical Center), Stephen J. Forman(City Of Hope National Medical Center)
Cited by 600
Related Papers
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|New England Journal of Medicine|1995|1.8k